DHT.UN — DRI Healthcare Trust Share Price
- CA$1.01bn
- CA$1.57bn
- $188.92m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 5.4 | ||
| PEG Ratio (f) | 0.09 | ||
| EPS Growth (f) | 146.92% | ||
| Dividend Yield (f) | 3.11% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.67 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 6.75 | ||
| Price to Sales | 3.69 | ||
| EV to EBITDA | 13.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.13% | ||
| Return on Equity | -10.42% | ||
| Operating Margin | -9.04% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 79.86 | 87.27 | 158.91 | 184.71 | 188.92 | 195.64 | 201.7 | 24.02% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -53.26 | n/a | n/a | n/a | n/a | +4.68 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DRI Healthcare Trust is a global pharmaceutical royalty monetization company. The Company's portfolio consists of 29 royalty streams on 23 products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. Its Royalty Assets include Ekterly, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Spinraza, Vonjo I, Vonjo II, Xolair, Zejula, Zytiga, and others. The Ekterly is an oral on-demand therapy for treating attacks associated with Hereditary Angioedema (HAE). The Eylea I is a vascular endothelial growth factor inhibitor initially indicated for the treatment of neovascular wet age-related macular degeneration. Natpara is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- March 31st, 2026
- Incorporated
- October 21st, 2020
- Public Since
- February 11th, 2021
- No. of Employees
- 32
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange
- Shares in Issue
- 55,016,156

- Address
- 1 First Canadian Place, Toronto, M5X 1B8
- Web
- https://drihealthcare.com/
- Phone
- +1 4168631865
- Auditors
- Deloitte LLP
Upcoming Events for DHT.UN
Q3 2026 Dri Healthcare Trust Earnings Release
Similar to DHT.UN
Aptose Biosciences
Toronto Stock Exchange
Aurora Cannabis
Toronto Stock Exchange
Auxly Cannabis
Toronto Stock Exchange
Bausch Health Companies
Toronto Stock Exchange
Canopy Growth
Toronto Stock Exchange
FAQ
As of Today at 20:19 UTC, shares in DRI Healthcare Trust are trading at CA$18.32. This share price information is delayed by 15 minutes.
Shares in DRI Healthcare Trust last closed at CA$18.32 and the price had moved by +41.03% over the past 365 days. In terms of relative price strength the DRI Healthcare Trust share price has outperformed the Toronto Stock Exchange 300 Composite Index by +8.31% over the past year.
The overall consensus recommendation for DRI Healthcare Trust is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe DRI Healthcare Trust dividend yield is 3.12% based on the trailing twelve month period.
Last year, DRI Healthcare Trust paid a total dividend of $0.41, and it currently has a trailing dividend yield of 3.12%.Looking ahead, shares in DRI Healthcare Trust are due to go ex-dividend on 2026-06-30 and the next dividend pay date is 2026-07-20.
DRI Healthcare Trust are due to go ex-dividend on 2026-06-30 and the next dividend pay date is 2026-07-20. The historic dividend yield on DRI Healthcare Trust shares is currently 3.12%.
To buy shares in DRI Healthcare Trust you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$18.32, shares in DRI Healthcare Trust had a market capitalisation of CA$1.01bn.
Here are the trading details for DRI Healthcare Trust:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: DHT.UN
Based on an overall assessment of its quality, value and momentum DRI Healthcare Trust is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in DRI Healthcare Trust is CA$23.53. That is 28.43% above the last closing price of CA$18.32.
Analysts covering DRI Healthcare Trust currently have a consensus Earnings Per Share (EPS) forecast of $2.39 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DRI Healthcare Trust. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +0.81%.
As of the last closing price of CA$18.32, shares in DRI Healthcare Trust were trading +14.79% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The DRI Healthcare Trust PE ratio based on its reported earnings over the past 12 months is 5.4. The shares last closed at CA$18.32.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on DRI Healthcare Trust's directors





